date,title,source
Oct-17-18,CORRECTING and REPLACING The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AbbVie Inc. (ABBV),Business Wire
Oct-17-18,SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against AbbVie Inc. - ABBV,ACCESSWIRE
Oct-17-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-17-18,Amgen Launches Humira Biosimilar in Europe,GuruFocus.com
Oct-17-18,EyePoint (EYPT) Gets FDA Approval for Eye Therapy Yutiq,Zacks
Oct-18-18,"Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-18-18,AbbVie Falls 3%,Investing.com
Oct-18-18,"Hagens Berman Reminds Investors in AbbVie Inc. (NYSE: ABBV) of the Firms Ongoing Investigation and the November 20, 2018 Securities Class Action Lead Plaintiff Deadline",GlobeNewswire
Oct-18-18,FDA Accepts Application for AbbVie's Imbruvica in Specific Blood Cancers,GuruFocus.com
Oct-19-18,"Investor Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-19-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,GlobeNewswire
Oct-19-18,ABBV NOTICE ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against AbbVie Inc.; Important Deadline  ABBV,GlobeNewswire
Oct-19-18,AbbVie CFO Chase to retire by mid-year 2019,Reuters
Oct-19-18,AbbVie CFO Chase to retire by mid-year 2019,Reuters
Oct-19-18,AbbVie names Robert Michael chief financial officer,Reuters
Oct-19-18,AbbVie CFO Bill Chase to retire,MarketWatch
Oct-22-18,Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis,PR Newswire
Oct-22-18,AbbVie Falls 3%,Investing.com
Oct-23-18,AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-23-18,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AbbVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 20, 2018  ABBV",GlobeNewswire
Oct-23-18,"ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In AbbVie, Inc. To Contact The Firm",Business Wire
Oct-23-18,"IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Oct-23-18,AbbVie rheumatoid arthritis drug succeeds in late stage trial,Reuters
Oct-23-18,AbbVie rheumatoid arthritis drug succeeds in late stage trial,Reuters
Oct-23-18,"Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines",Zacks
Oct-23-18,"AbbVie's Upadacitinib Shows Significant Improvements in Physical Function, Pain and Quality of Life as a Monotherapy in Patients with Rheumatoid Arthritis in Phase 3 Patient-Reported Outcomes Data",PR Newswire
Oct-23-18,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",Benzinga
Oct-23-18,Today's Research Reports on Trending Tickers: AbbVie and Endo International,ACCESSWIRE
Oct-24-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-24-18,AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program,PR Newswire
Oct-24-18,Galapagos and AbbVie restructure CF collaboration,GlobeNewswire
Oct-24-18,"IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-24-18,AbbVie Falls 3%,Investing.com
Oct-24-18,Healthcare ETFs to Buy Ahead of Q3 Earnings,Zacks
Oct-24-18,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",Benzinga
Oct-24-18,3 Healthcare Stocks I'd Buy Right Now,Motley Fool
Oct-25-18,"IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-25-18,SHAREHOLDER ALERT: MCHP ABBV MGTI HAS ACHC ADNT TRVN HTHT GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-25-18,AbbVie Rises 3%,Investing.com
Oct-25-18,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",Benzinga
Oct-26-18,"Abbott, AbbVie settle TriCor marketing case for $25 mln",Reuters
Oct-26-18,"Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln",Reuters
Oct-26-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, ACHC, ADNT, HTHT and CWH",GlobeNewswire
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,AbbVie (ABBV) Q3 Earnings Preview: What's Shaping Up?,Zacks
Oct-26-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline  November 20, 2018",GlobeNewswire
Oct-29-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PM, TGTX, ABBV, HTHT and SFIX",GlobeNewswire
Oct-29-18,"IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Oct-29-18,November 20th AbbVie Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against AbbVie Inc. - ABBV,GlobeNewswire
Oct-29-18,53 Best Dividend Stocks for 2018 and Beyond,Kiplinger
Oct-30-18,"IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-30-18,SHAREHOLDER ALERT: COCP TGTX ABBV ALNY MGTI HAS CPB HTHT SFIX GOOG OZK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-30-18,Why this East Bay drug maker plans to add 300 jobs,American City Business Journals
Oct-30-18,Pawar Law Group Announces a Securities Class Action Lawsuit Against AbbVie Inc. - ABBV,ACCESSWIRE
Oct-30-18,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AbbVie Inc. (NYSE: ABBV) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",GlobeNewswire
Oct-30-18,What's in the Cards for AbbVie (ABBV) This Earnings Season?,Zacks
Oct-31-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-31-18,"AbbVie, Roche combo treatment meets main goal of leukemia trial",Reuters
Oct-31-18,SHAREHOLDER ALERT: OPK PVG USAT ABBV CHGG ACHC JT ADNT GOOG CWH OZK DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-31-18,"AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia",PR Newswire
Oct-31-18,AbbVie Falls 3%,Investing.com
Oct-31-18,"SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-31-18,"CLASS ACTION UPDATE for ABBV, JT and OZK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,Neurocrine (NBIX) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-31-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline  November 20, 2018",GlobeNewswire
Nov-01-18,AbbVie's Leukemia Treatment Gets EU Regulatory Nod; Shares Rise 3%,Investing.com
Nov-01-18,"Bottom fishers, these stocks are within 5% of their 52-week lows",MarketWatch
Nov-01-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, PVG, COCP, ABBV and ADNT",GlobeNewswire
Nov-01-18,Todays Research Reports on Stocks to Watch: Aeterna Zentaris and AbbVie,ACCESSWIRE
Nov-01-18,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",Benzinga
Nov-01-18,"AbbVie, Roche combo treatment meets main goal of leukemia trial",Reuters
Nov-02-18,"DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Nov-02-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,GlobeNewswire
Nov-02-18,5 Income Stocks for Massive Payouts and Steady Growth,InvestorPlace
Nov-02-18,SHAREHOLDER ALERT: OPK PM QRTEA TRCO PVG COCP ABBV ALNY MGTI CHGG CWH DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-02-18,AbbVie's Q3 Update: 3 Things You Need to Know,Motley Fool
Nov-02-18,AbbVie Inc (ABBV) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-02-18,AbbVie sees hit to Humira sales from European competition,Reuters
Nov-02-18,Edited Transcript of ABBV earnings conference call or presentation 2-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-02-18,AbbVie sees hit to Humira sales from European competition,Reuters
Nov-02-18,ABBV LOSSES ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against AbbVie Inc.; Important Deadline  ABBV,GlobeNewswire
Nov-02-18,AbbVie Best-Seller Humira Shows Its Mortality,Bloomberg
Nov-02-18,"AbbVie's (ABBV) Q3 Earnings Beat Estimates, 2018 EPS View Up",Zacks
Nov-02-18,AbbVie Stock Jumps Higher on Q3 Earnings Beat,InvestorPlace
Nov-02-18,"CLASS ACTION UPDATE for ABBV, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Nov-02-18,3 Stocks That Got Dividend Hikes This Week,Barrons.com
Nov-02-18,"AbbVie Earnings, Revenue beat in Q3",Investing.com
Nov-02-18,Humira biosimilars available at up to 80 percent discount in Europe: AbbVie,Reuters
Nov-02-18,AbbVie expects double-digit earnings growth in 2019,Reuters
Nov-02-18,AbbVie expects double-digit earnings growth in 2019,Reuters
Nov-02-18,AbbVie (ABBV) Tops Q3 Earnings Estimates,Zacks
Nov-02-18,AbbVie lifts profit target after cancer drug powers quarterly beat,Reuters
Nov-02-18,"Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus",Zacks
Nov-02-18,AbbVie: 3Q Earnings Snapshot,Associated Press
Nov-02-18,AbbVie shares jump 3% premarket after earnings beat and higher guidance,MarketWatch
Nov-02-18,AbbVie Reports Third-Quarter 2018 Financial Results,PR Newswire
Nov-02-18,"Dow jumps 150 points after strong jobs report, but Apple's loss drags down the Nasdaq",CNBC
Nov-05-18,"CLASS ACTION UPDATE for OPK, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Nov-05-18,"INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Nov-05-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, MCHP, ABBV, ALNY and CHGG",GlobeNewswire
Nov-05-18,AbbVie Rises 3%,Investing.com
Nov-05-18,What's Ahead for AbbVie After Earnings and Revenue Beat?,GuruFocus.com
Nov-05-18,November 20th AbbVie Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against AbbVie Inc. - ABBV,GlobeNewswire
Nov-05-18,Edited Transcript of ABBV earnings conference call or presentation 2-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Edited Transcript of ABBV earnings conference call or presentation 2-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,"ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In AbbVie, Inc. To Contact The Firm",GlobeNewswire
Nov-07-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline - ABBV,PR Newswire
Nov-07-18,Better Buy: Eli Lilly and Company vs. AbbVie Inc.,Motley Fool
Nov-07-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USAT, ABBV, MGTI and JT",GlobeNewswire
Nov-07-18,"All this 500,000-square-foot Berkeley biotech project needs is a developer",American City Business Journals
Nov-07-18,AbbVie Rises 3%,Investing.com
Nov-07-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018",ACCESSWIRE
Nov-07-18,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",Benzinga
Nov-08-18,AbbVie (ABBV) Gains As Market Dips: What You Should Know,Zacks
Nov-08-18,AbbVie Rises 3%,Investing.com
Nov-08-18,SHAREHOLDER ALERT: MCHP COCP ABBV JT TRVN SFIX CWH HON ALGN NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-08-18,"Investor Expectations to Drive Momentum within AbbVie, Ducommun, Life Storage, NMI, Church & Dwight Co., and Lumentum  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-09-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,GlobeNewswire
Nov-09-18,Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices,PR Newswire
Nov-09-18,Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-09-18,"CLASS ACTION UPDATE for ABBV, HON and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Nov-09-18,AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset,PR Newswire
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-12-18,SHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-12-18,"INVESTOR REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Nov-12-18,Why AbbVie's Stock Cratered in October,Motley Fool
Nov-14-18,AbbVie (ABBV) Gains As Market Dips: What You Should Know,Zacks
Nov-14-18,AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress,PR Newswire
Nov-14-18,"CLASS ACTION UPDATE for ABBV, CHGG and HTHT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Nov-14-18,AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study,Zacks
Nov-14-18,"6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Nov-14-18,November 20th AbbVie Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against AbbVie Inc. - ABBV,GlobeNewswire
Nov-14-18,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018",ACCESSWIRE
Nov-14-18,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark",Zacks
Nov-15-18,"ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in AbbVie, Inc. to Contact the Firm",ACCESSWIRE
Nov-15-18,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",Benzinga
Nov-16-18,101 Best Dividend Stocks to Buy for 2019 and Beyond,Kiplinger
Nov-16-18,WeissLaw LLP: AbbVie Inc. is the Subject of a Legal Investigation,ACCESSWIRE
Nov-16-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY",GlobeNewswire
Nov-16-18,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018",ACCESSWIRE
Nov-16-18,11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure,Benzinga
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-19-18,Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids,Zacks
Nov-19-18,"CLASS ACTION UPDATE for ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Nov-19-18,"DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
Nov-19-18,Should Value Investors Consider AbbVie (ABBV) Stock Now?,Zacks
Nov-19-18,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline  November 20, 2018",ACCESSWIRE
Nov-20-18,AbbVie (ABBV) Stock Moves -1.55%: What You Should Know,Zacks
Nov-20-18,3 Top Large-Cap Stocks to Buy in November,Motley Fool
Nov-20-18,SHAREHOLDER ALERT: ABBV JT CWH HON DY RYAAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Nov-20-18,"DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Nov-20-18,"FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018",ACCESSWIRE
Nov-20-18,AbbVie to Highlight Breadth of Innovative Science and Ongoing Commitment to Blood Cancer Patients with New Data From Studies of Ibrutinib and Venetoclax at 2018 American Society of Hematology Annual Meeting & Exposition,PR Newswire
Nov-20-18,Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie,ACCESSWIRE
Nov-23-18,FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia,GuruFocus.com
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-26-18,2 Dividend Stocks You'll Wish You'd Bought 32 Years From Now,Motley Fool
Nov-26-18,"The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca",Zacks
Nov-26-18,"Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth",Zacks
Nov-27-18,"Wall Street Wants the Best Patents, Not the Best Drugs",Bloomberg
Nov-28-18,AbbVie (ABBV) Gains But Lags Market: What You Should Know,Zacks
Nov-28-18,3 Themes To Watch As Biopharmas 'Bring Some Excitement' In Blood Cancer,Investor's Business Daily
Nov-28-18,Vertex's (VRTX) Triple Combo Cystic Fibrosis Studies Succeed,Zacks
Nov-28-18,3 Top Stocks With High Dividend Yields,Motley Fool
Nov-30-18,U.S. Stocks Sprint Ahead to End a Blockbuster Week,Barrons.com
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Nov-30-18,AbbVie Rises 3%,Investing.com
Nov-30-18,"U.S.-China Trade Talks In Focus, While Just One Stock Sector Stands Out",Investor's Business Daily
Nov-30-18,The New Amazon Blockchain Products Could Be Huge for AMZN,InvestorPlace
Dec-04-18,AbbVie Falls 3%,Investing.com
Dec-04-18,7 Stocks Wall Street Is Souring on Right Now,Kiplinger
Dec-04-18,Roche Announces Positive Data on Venclexta/Venclyxto at ASH,Zacks
Dec-06-18,AbbVie Falls 3%,Investing.com
Dec-06-18,AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study,Zacks
Dec-06-18,AbbVie Stock Has a $10 Upside Opportunity  Buy It Now,InvestorPlace
Dec-06-18,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",Benzinga
Dec-07-18,AbbVie Falls 4%,Investing.com
Dec-07-18,Is AbbVie Inc (ABBV) A Good Stock To Buy?,Insider Monkey
Dec-10-18,Dont Punish Gilead Stock for Doing Its Job,InvestorPlace
Dec-10-18,"Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend",Zacks
Dec-11-18,Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO,Zacks
Dec-11-18,7 Stocks Wall Street Is Souring on Right Now,Kiplinger
Dec-11-18,Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800,Zacks
Dec-11-18,How Worried Should You Be About AbbVie's $5.8 Billion Boondoggle?,Motley Fool
Dec-12-18,5 Pharma Stocks That Could Cure Ailing Portfolios in 2019,InvestorPlace
Dec-12-18,AbbVie- High Yield at a Low Valuation,MoneyShow
Dec-13-18,AbbVie Announces $5 Billion Increase to Stock Repurchase Program,PR Newswire
Dec-14-18,AbbVie May Yield More Than It Appears,GuruFocus.com
Dec-17-18,AbbVie (ABBV) Stock Moves -0.79%: What You Should Know,Zacks
Dec-17-18,AbbVie Announces Executive Leadership Changes,PR Newswire
Dec-17-18,Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial,Reuters
Dec-18-18,Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study,Zacks
Dec-18-18,"The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney",Zacks
Dec-19-18,This High-Yield Dividend Stock Could Outperform If the Stock Market Rallies,GuruFocus.com
Dec-19-18,Why Eli Lilly Stock Is Still Shining in the Darkness,InvestorPlace
Dec-19-18,Today's Research Reports on Trending Tickers: Dr. Reddy's Laboratories and AbbVie,ACCESSWIRE
Dec-20-18,AbbVie Rises 3%,Investing.com
Dec-20-18,AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis,PR Newswire
Dec-20-18,AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Dec-20-18,3 Top Healthcare Stocks to Buy in December,Motley Fool
Dec-24-18,AbbVie (ABBV) Stock Moves -0.89%: What You Should Know,Zacks
Dec-26-18,Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?,Investor's Business Daily
Dec-26-18,AbbVie Partners Lupin to Boost Hematological Cancer Pipeline,Zacks
Dec-26-18,AbbVie Rises 3%,Investing.com
Dec-27-18,AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV,InvestorPlace
Dec-28-18,AbbVie Rises 3%,Investing.com
Dec-28-18,AbbVie: A Low-Risk Income Stock That Gives Investors Exposure to the Marijuana Industry,GuruFocus.com
Dec-28-18,2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma,American City Business Journals
Dec-28-18,Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?,Zacks
Dec-31-18,AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know,Zacks
Dec-31-18,The Most Promising Biotech Names Heading Into 2019,Investopedia
Jan-02-19,Drug companies greet 2019 with U.S. price hikes,Reuters
Jan-02-19,Drug companies greet 2019 with U.S. price hikes,Reuters
Jan-02-19,Stay with IBM? What's up with Blackstone? That and more i...,CNBC Videos
Jan-02-19,AbbVie Falls 3%,Investing.com
Jan-03-19,Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid,Investor's Business Daily
Jan-03-19,3 Biopharma Stocks to Buy for Their Robust Dividend Yields,InvestorPlace
Jan-03-19,Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid,Investor's Business Daily
Jan-03-19,Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?,Zacks
Jan-03-19,AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39,PR Newswire
Jan-03-19,"3 Big Stock Charts for Thursday: Medtronic, Facebook and eBay",InvestorPlace
Jan-03-19,AbbVie to Host Fourth-Quarter and Full-Year 2018 Earnings Conference Call,PR Newswire
Jan-04-19,Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine?,Investor's Business Daily
Jan-04-19,"Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",Zacks
Jan-04-19,AbbVie Rises 3%,Investing.com
Jan-04-19,Pfizer Begins Pivotal Study on Alopecia Areata Candidate,Zacks
Jan-07-19,AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know,Zacks
Jan-07-19,Peninsula Alzheimer's fighter hunts $150 million IPO,American City Business Journals
Jan-07-19,"Neurocrine Gives Ingrezza Sales View, Updates on Pipeline",Zacks
Jan-07-19,"As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock",InvestorPlace
Jan-07-19,Gilead (GILD) Collaborates With Yuhan for NASH Candidates,Zacks
Jan-07-19,"Jim Cramer Gives His Opinion On Ciena, Momo, Qualcomm And More",Benzinga
Jan-07-19,Neurocrine Biosciences Is a Pharma Stock to Watch,InvestorPlace
Jan-07-19,Today's Research Reports on Trending Tickers: AbbVie and Allergan,ACCESSWIRE
Jan-07-19,"The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie",Zacks
Jan-08-19,"Top Analyst Reports for Visa, Coca-Cola & AbbVie",Zacks
Jan-09-19,AbbVie Falls 3%,Investing.com
Jan-09-19,Is AbbVie (ABBV) a Great Value Stock Right Now?,Zacks
Jan-09-19,"The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy",Zacks
Jan-09-19,Novartis' Crizanlizumab Gets Breakthrough Therapy Status,Zacks
Jan-09-19,Inside look: LNG bunker that puts Jaxport on world map,American City Business Journals
Jan-09-19,Top Picks 2019- AbbVie Inc. ABBV,MoneyShow
Jan-10-19,101 Best Dividend Stocks to Buy for 2019 and Beyond,Kiplinger
Jan-10-19,6 High-Cap Stocks Paying High Dividend Yields,GuruFocus.com
Jan-10-19,3 Dividend Stocks That Pay You Better Than Coca-Cola Does,Motley Fool
Jan-10-19,3 Big Reasons Why AbbVie Isn't Worried About Humira,Motley Fool
Jan-10-19,Top Ranked Momentum Stocks to Buy for January 10th,Zacks
Jan-11-19,5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019,Zacks
Jan-11-19,Top Ranked Momentum Stocks to Buy for January 11th,Zacks
Jan-11-19,"Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",Zacks
Jan-14-19,Democrats target drug prices,CNBC Videos
Jan-14-19,Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe,Investor's Business Daily
Jan-14-19,U.S. lawmaker launches investigation into pharma drug pricing,Reuters
Jan-14-19,House Democrats launch drug-pricing probe into a dozen major health-care companies,CNBC
Jan-14-19,Top Ranked Growth Stocks to Buy for January 14th,Zacks
Jan-15-19,Drug companies greet 2019 with U.S. price hikes,Reuters
Jan-16-19,Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings,Zacks
Jan-16-19,Will Dividend Stocks be the Hot Stocks of 2019?,Zacks
Jan-16-19,Katz:  Markets are looking past several negative headline...,CNBC Videos
Jan-17-19,Banks Keep Stocks Moving Higher,Zacks
Jan-17-19,"Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&amp;T and Verizon",Zacks
Jan-17-19,Trending: Investors Turn to Dividend Aristocrats Amid Market Volatility,ETF Database
Jan-18-19,AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study,Reuters
Jan-18-19,AbbVie's cancer drug fails to meet main goal in late-stage study,Reuters
Jan-22-19,5 Amazing Earnings Charts,Zacks
Jan-22-19,"J&amp;J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft",Zacks
Jan-22-19,Bet on These 5 Low Leverage Stocks to Secure Returns,Zacks
Jan-22-19,Better Buy: Pfizer vs. AbbVie,Motley Fool
Jan-23-19,"Top Research Reports for Amazon, Verizon & AbbVie",Zacks
Jan-23-19,Is a Beat in Store for AbbVie (ABBV) This Earnings Season?,Zacks
Jan-24-19,Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?,Zacks
Jan-24-19,Q4 Earnings Preview For AbbVie,Benzinga
Jan-24-19,What's Behind the Biotech ETF Rally to Start 2019?,Zacks
Jan-24-19,Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?,Zacks
Jan-24-19,Healthcare ETFs in Focus Ahead of Q4 Earnings,Zacks
Jan-24-19,"The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb",Zacks
Jan-24-19,"Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie",Zacks
Jan-24-19,Is a Surprise Coming for AbbVie (ABBV) This Earnings Season?,Zacks
Jan-24-19,3 Things to Expect in AbbVie's Q4 Earnings Update,Motley Fool
Jan-24-19,AbbVie Falls 3%,Investing.com
Jan-25-19,"Western Digital, Starbucks rise while AbbVie, Intel drop",Associated Press
Jan-25-19,"Why Intel, AbbVie, and Vale Slumped Today",Motley Fool
Jan-25-19,AbbVie Stock Crumbles After Biosimilars Take A Chunk Of Humira Sales,Investor's Business Daily
Jan-25-19,AbbVie Falls After Missing Top- and Bottom-Line Estimates,TheStreet.com
Jan-25-19,AbbVie Inc (ABBV) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Jan-25-19,AbbVie Q4 Earnings: 3 Key Things You Need to Know,Motley Fool
Jan-25-19,Celgene Stock Is Rising After the CEO of AbbVie Ruled Out a Big Deal,Barrons.com
Jan-25-19,[$$] Drug Maker AbbVie Swings to Loss on Charge from Stemcentrx Deal,The Wall Street Journal
Jan-25-19,AbbVie Earnings: ABBV Stock Falters on Q4 Miss,InvestorPlace
Jan-25-19,AbbVie expects steeper decline in Humira's overseas sales; shares fall,Reuters
Jan-25-19,Congressional Activities on Shutdown in Focus,Zacks
Jan-25-19,"AbbVie (ABBV) Misses on Q4 Earnings &amp; Revenues, Shares Down",Zacks
Jan-25-19,"Asia, Congress Activity, Put Futures in the Green",Zacks
Jan-25-19,"Pharma Stock Roundup: JNJ &amp; BMY's Q4 Earnings, Study Failures at LLY &amp; ABBV",Zacks
Jan-25-19,AbbVie not contemplating big deals - CEO,Reuters
Jan-25-19,US STOCKS-Wall St set to open higher as investors focus on upbeat earnings,Reuters
Jan-25-19,"AbbVie (ABBV) Misses Q4 Earnings and Revenues, Shares Down",Zacks
Jan-25-19,AbbVie (ABBV) Lags Q4 Earnings and Revenue Estimates,Zacks
Jan-25-19,AbbVie: 4Q Earnings Snapshot,Associated Press
Jan-25-19,Abbvie shares slide 2.3% premarket after earnings miss,MarketWatch
Jan-25-19,AbbVie profit misses as Humira faces biosimilar challenge in Europe,Reuters
Jan-25-19,AbbVie profit misses as Humira faces biosimilar challenge in Europe,Reuters
Jan-25-19,AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results,PR Newswire
Jan-25-19,"AbbVie Earnings, Revenue miss in Q4",Investing.com
Jan-28-19,Is AbbVie in Hot Water?,GuruFocus.com
Jan-28-19,Analysts Cut AbbVie Price Targets After Earnings Miss,Benzinga
Jan-28-19,"Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB &amp; AGN",Zacks
Jan-28-19,"The Zacks Analyst Blog Highlights: J&amp;J, Bristol-Myers, Lilly, AbbVie and Merck",Zacks
Jan-28-19,This is Why AbbVie (ABBV) is a Great Dividend Stock,Zacks
Jan-29-19,AbbVie (ABBV) Gains As Market Dips: What You Should Know,Zacks
Jan-29-19,10 Value Stocks to Buy for 2019 and Beyond,Kiplinger
Jan-29-19,"Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Jan-29-19,Jacksonville's increasing use of LNG as a transportation fuel,American City Business Journals
Jan-29-19,3 Top Dividend Stocks to Buy Right Now,Motley Fool
Jan-29-19,AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting,Zacks
Jan-29-19,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",Benzinga
Jan-30-19,ABBV Stock Is Worth a Look at Multi-Year Lows,InvestorPlace
Jan-30-19,Genentech kills big drug study in early Alzheimer's patients,American City Business Journals
Jan-30-19,3 Big Pharmas Expecting a Softer 2019,Motley Fool
Jan-30-19,"Jim Cramer Gives His Opinion On AbbVie, Idexx Labs And More",Benzinga
Jan-31-19,"Top Research Reports for Union Pacific, AbbVie & General Dynamics",Zacks
Feb-01-19,Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance,Zacks
Feb-01-19,"The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics",Zacks
Feb-01-19,"Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",Zacks
Feb-01-19,The 12 Best Dividend Aristocrats- Part 1,MoneyShow
Feb-04-19,AbbVie Falls 3%,Investing.com
Feb-05-19,Merck CEO Frazier to testify at Senate drug pricing hearing,Reuters
Feb-05-19,3 Red-Hot Stocks (And 3 That Arent),InvestorPlace
Feb-05-19,"Pharma execs will testify before Congress 'one way or another,' US senator says",CNBC
Feb-05-19,Top Marijuana Stocks That Pay Dividends,Investopedia
Feb-05-19,Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies,Zacks
Feb-05-19,"Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm",PR Newswire
Feb-06-19,At least four pharma CEOs to testify at Senate drug pricing hearing,Reuters
Feb-06-19,At least four pharma CEOs to testify at Senate drug pricing hearing,Reuters
Feb-06-19,Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying,CNBC
Feb-08-19,Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?,CNBC Videos
Feb-11-19,Here's Why Coherus BioSciences Rose 48.7% in January,Motley Fool
Feb-11-19,AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma,PR Newswire
Feb-12-19,AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma,Zacks
Feb-12-19,5 Aristocrats for Stable Income,MoneyShow
Feb-13-19,AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?,Zacks
Feb-15-19,AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc.,Moody's
Feb-15-19,[$$] WSJ Tax Guide 2019: The Drug Industry,The Wall Street Journal
Feb-19-19,Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review,Zacks
Feb-19-19,2 Pharma Stocks in the Middle of an Oncology Sales Explosion,Motley Fool
Feb-19-19,AbbVie stock up 0.2% after FDA grants upadacitinib priority review status,MarketWatch
Feb-19-19,AbbVie Announces New Drug Application Accepted for Priority Review by U.S. FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis,PR Newswire
Feb-20-19,AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review,Zacks
Feb-21-19,AbbVie Declares Quarterly Dividend,PR Newswire
Feb-21-19,"The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan",Benzinga
Feb-21-19,Waltham biotech Morphic signs $725M partnership with Janssen,American City Business Journals
Feb-22-19,Why Voyager Therapeutics Is Skyrocketing Today,Motley Fool
Feb-22-19,Voyager Therapeutics stock jumps on 2nd Parkinson's deal,American City Business Journals
Feb-22-19,Voyager Shares Take Off on Parkinson's Disease Development Deal,TheStreet.com
Feb-22-19,"Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates",Zacks
Feb-22-19,Voyager Therapeutics stock soars after AbbVie collaboration potentially valued at over $1 billion,MarketWatch
Feb-22-19,AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies,PR Newswire
Feb-25-19,Technician says it's time to fade the biotech rally,CNBC Videos
Feb-25-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-25-19,Factbox: Pharma company executives to testify at U.S. Senate drug price hearing,Reuters
Feb-25-19,[$$] Pharmaceutical Industry CEOs Face Senate Hearing on Drug Prices,The Wall Street Journal
Feb-25-19,"Momenta (MNTA) Q4 Loss Narrower Than Expected, Revenues Beat",Zacks
Feb-25-19,"The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie",Zacks
Feb-25-19,AbbVie to Showcase Scientific Innovation and Research Advancements Across Dermatology Portfolio at 2019 AAD Annual Meeting,PR Newswire
Feb-25-19,AbbVie Extends Deal With Voyager to Make Parkinson's Drugs,Zacks
Feb-26-19,Lawmakers grill top pharma execs over high drug costs,CNBC Videos
Feb-26-19,"[$$] CEOs From Pfizer, Merck and Others Face Senate Over Drug Pricing",The Wall Street Journal
Feb-27-19,Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You,Motley Fool
Feb-27-19,Senate panel grills pharma CEO over executive bonuses. Calls tie to sales of AbbVie blockbuster drug Humira 'problematic',CNBC
Feb-28-19,These 10 New Drugs Expected In 2019 Are On The Blockbuster Track,Investor's Business Daily
Feb-28-19,Is now the time to buy Rio Tinto? How does Abbvie look here? The desk answers your questions,CNBC Videos
Feb-28-19,3 Top Stocks With High Dividend Yields,Motley Fool
Feb-28-19,AbbVie to Present at the Cowen Health Care Conference,PR Newswire
Feb-28-19,"10 Stocks With Safe, Generous Dividends",Barrons.com
Mar-01-19,"Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices",Zacks
Mar-01-19,AbbVie to Present at the Barclays Global Healthcare Conference,PR Newswire
Mar-01-19,AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI) for the Treatment of Moderate to Severe Plaque Psoriasis,PR Newswire
Mar-04-19,"Top Research Reports for Intel, AbbVie & United Technologies",Zacks
Mar-04-19,AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab,Zacks
Mar-05-19,Top Marijuana Stocks That Pay Dividends,Investopedia
Mar-05-19,"The Zacks Analyst Blog Highlights: Intel, AbbVie, United Technologies, Simon Property and FirstEnergy",Zacks
Mar-06-19,Bio-Path stock soars in active trade after announcing Phase 2 trial update,MarketWatch
Mar-06-19,7 Stocks That Can Outperform In a Post QE Market,Investopedia
Mar-06-19,Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice,Zacks
Mar-07-19,The Kiplinger Dividend 15 Is On a Roll,Kiplinger
Mar-07-19,UPDATE: Bio-Path stock gains another 130% on Thursday,MarketWatch
Mar-07-19,AbbVie Announces Multiple Milestones for Phase 3 CLL14 Venetoclax Study of Fixed Duration Treatment in Previously-Untreated Chronic Lymphocytic Leukemia Patients,PR Newswire
Mar-07-19,Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed,Zacks
Mar-07-19,2 Biotech Stocks With Major Incoming Catalysts,Motley Fool
Mar-08-19,"Pharma Stock Roundup: FDA OK's J&amp;J Antidepressant, CHMP Recommends Several Drugs",Zacks
Mar-08-19,Dont Abandon Gilead Stock After Weak Q4 Results,InvestorPlace
Mar-08-19,Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC,Zacks
Mar-11-19,AbbVie (ABBV) Gains But Lags Market: What You Should Know,Zacks
Mar-11-19,Should Value Investors Consider Abbvie (ABBV) Stock Now?,Zacks
Mar-12-19,Takeda's Entyvio Tops AbbVie's Humira in Patients With Ulcerative Colitis,GuruFocus.com
Mar-12-19,Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval,Zacks
Mar-13-19,Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study,Zacks
Mar-14-19,Roche Receives EC Approval for Label Expansion of Hemlibra,Zacks
Mar-14-19,3 Dividend Aristocrats to Buy and Hold Forever,Motley Fool
Mar-14-19,The Timely Ten- Blue Chip Buys with Value and Yield,MoneyShow
Mar-14-19,Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades,Investopedia
Mar-18-19,Big Pharma Earnings Might Not Be as Good as They Look,Barrons.com
Mar-19-19,Why You Should Buy ABBV Stock for Income and Value,InvestorPlace
Mar-19-19,FDA puts partial hold on clinical trials of AbbVie's cancer drug,Reuters
Mar-19-19,AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myeloma,MarketWatch
Mar-19-19,FDA puts partial hold on clinical trials of AbbVie's cancer drug,Reuters
Mar-20-19,AbbVie's Venclexta Multiple Myeloma Studies Put on Hold by FDA,Zacks
Mar-21-19,"Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons",InvestorPlace
Mar-22-19,This is Why AbbVie (ABBV) is a Great Dividend Stock,Zacks
Mar-25-19,AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know,Zacks
Mar-26-19,AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan,Zacks
Mar-26-19,Were Hedge Funds Right About AbbVie Inc (ABBV)?,Insider Monkey
Mar-26-19,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs",Benzinga
Mar-26-19,"AbbVie Announces First Regulatory Approval of SKYRIZI (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan",PR Newswire
Mar-27-19,"How this cancer-fighting startup switched gears, landed a big deal and started a clinical trial",American City Business Journals
Mar-28-19,"Drug giant cutting 178 jobs, three years after buying Peninsula biotech for $6 billion",American City Business Journals
Mar-29-19,Can These Biotech Stocks Take On Arthritis Powerhouse AbbVie?,Investor's Business Daily
Mar-29-19,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,Benzinga
Mar-29-19,Can These Biotech Stocks Take On Arthritis Powerhouse AbbVie?,Investor's Business Daily
Apr-01-19,AbbVie (ABBV) Gains But Lags Market: What You Should Know,Zacks
Apr-01-19,Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimers Disease,GlobeNewswire
Apr-01-19,Here's what to expect from the stock market next month,Investopedia
Apr-02-19,AbbVie Rises 3%,Investing.com
Apr-03-19,Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003,Zacks
Apr-03-19,AbbVie to Host First-Quarter 2019 Earnings Conference Call,PR Newswire
Apr-04-19,10 Medical Marijuana Stocks to Cure Your Portfolio,InvestorPlace
Apr-04-19,AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRET,CNW Group
Apr-04-19,Novartis Resubmits BLA to FDA for Biosimilar of Neulasta,Zacks
Apr-05-19,AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP,GuruFocus.com
Apr-05-19,"Top Stock Reports for Boeing, Lockheed Martin & Anthem",Zacks
Apr-08-19,AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know,Zacks
Apr-08-19,J&amp;J Stock on an Uptrend This Year So Far: More Room to Run?,Zacks
Apr-10-19,Here's what to expect from the stock market next month,Investopedia
Apr-10-19,J&amp;J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?,Zacks
Apr-11-19,AbbVie's MAVIRET now reimbursed in Quebec,CNW Group
Apr-12-19,Looking for a job? Here's the 2018 median pay at 50 top U.S. companies,American City Business Journals
Apr-12-19,Forward Guidance Will Make or Break JNJ Earnings,InvestorPlace
Apr-12-19,Do CEOs really make 100 times more than employees? They do at these big U.S. companies,American City Business Journals
Apr-15-19,AbbVie (ABBV) Gains As Market Dips: What You Should Know,Zacks
Apr-15-19,8 Dividend Rich Blue Chips to Prosper as Buyback Mania Fades,Investopedia
Apr-16-19,Top Marijuana Stocks That Pay Dividends,Investopedia
Apr-16-19,"J&amp;J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View",Zacks
Apr-16-19,Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?,InvestorPlace
Apr-18-19,Can Q1 Earnings Lift Healthcare ETFs Higher?,Zacks
Apr-18-19,AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?,Zacks
Apr-18-19,Here Are the Key Takeaways From J&amp;J's Q1 Earnings Report,Zacks
Apr-18-19,Health Canada Approves SKYRIZI (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis,CNW Group
Apr-22-19,Better Buy: Biogen vs. AbbVie,Motley Fool
Apr-22-19,Is a Beat in Store for AbbVie (ABBV) This Earnings Season?,Zacks
Apr-22-19,Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-22-19,AbbVie Reports Its Q1 Results on Thursday: Here's What You Can Expect,Motley Fool
Apr-23-19,AbbVie stock ticks higher on FDA approval of psoriasis treatment,MarketWatch
Apr-23-19,AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis,PR Newswire
Apr-23-19,"You can find plenty of solid stock bargains in this years worst-performing sector, analyst says",MarketWatch
Apr-24-19,Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?,Zacks
Apr-24-19,Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-24-19,AbbVie Expected to Earn $2.06 a share,TheStreet.com
Apr-24-19,AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Heres what to expect,MarketWatch
Apr-24-19,5 Turnaround Earnings Charts You Must See,Zacks
Apr-24-19,"Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales",Zacks
Apr-24-19,Why Earnings Season Could Be Great for AbbVie (ABBV),Zacks
Apr-24-19,"You can find plenty of solid stock bargains in this years worst-performing sector, analysts say",MarketWatch
Apr-24-19,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova",Benzinga
Apr-25-19,AbbVie Inc (ABBV) Q1 2019 Earnings Call Transcript,Motley Fool
Apr-25-19,These Pharmas Beat First-Quarter Forecasts; But Biosimilars Rankled One,Investor's Business Daily
Apr-25-19,"AbbVie Climbs Earnings Beat, Guidance Boost",TheStreet.com
Apr-25-19,What You Need to Know About AbbVie's Surprisingly Strong Q1 Earnings,Motley Fool
Apr-25-19,"Biosimilar competition to AbbVies Humira is eroding profits, but company says it has confidence in pipeline",MarketWatch
Apr-25-19,Here's Why The Bacteria In Your Gut Could Be A Blockbuster Opportunity,Investor's Business Daily
Apr-25-19,"AbbVie raises profit forecast, but Humira concerns weigh on shares",Reuters
Apr-25-19,"AbbVie (ABBV) Beats on Q1 Earnings &amp; Sales, Raises EPS View",Zacks
Apr-25-19,AbbVie Is Losing Its Humira Safety Blanket,Bloomberg
Apr-25-19,"AbbVie says Humira rivals from Biogen, Amgen most aggressive so far",Reuters
Apr-25-19,"AbbVie (ABBV) Beats Q1 Earnings and Revenues, Shares Up",Zacks
Apr-25-19,AbbVie raises forecasts despite pressure on Humira,Financial Times
Apr-25-19,AbbVie stock up 2% after earnings beat and raised outlook,MarketWatch
Apr-25-19,"The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings",Benzinga
Apr-25-19,AbbVie: 1Q Earnings Snapshot,Associated Press
Apr-25-19,AbbVie Reports First-Quarter 2019 Financial Results,PR Newswire
Apr-25-19,"AbbVie Earnings, Revenue Beat in Q1",Investing.com
